Methods: The ability of 161Tb- and 177Lu-radiolabeled anti-CD30 antibody (cAC10) to reduce cell viability and survival and induce DNA damage was evaluated in vitro in CD30-positive T-cell lymphoma cell lines. This evidence concerns the gene TNFRSF8 and T-cell non-Hodgkin lymphoma.